“To me, this is the biggest contrarian bet you can make today. If you’ve got the guts to make the trade, it could lead to massive upside from here,” says the author of today’s article in regards to the investment opportunity he outlines – one that involves an investment that, being cheap, hated and in the start of an uptrend,…
The coronavirus pandemic is surging. The economy is in a precarious state. The outcome of the presidential election may well be contested. International tensions are rising. And the author of today’s article advises that “These risks are presenting a once-in-a-lifetime chance to turbocharge your investment gains.” How? By trading options, which he argues is easier than many investors think. For…
As investors attempt to identify the COVID-19 vaccine stock that will beat all the others, biotech has become one of the hottest sectors, with the S&P Biotech SPDR ETF having jumped nearly 80% since hitting its March low. Today’s article offers an analysis of three specific biotech stocks and insights on what to do with each if you are considering…
In the current market environment, the author of today’s article notes that “As a stock picker, it’s important to find areas where the risk and reward proposition is more positive,” and advises that “One of the areas where this is best exhibited is with emerging markets.” He proceeds to highlight three emerging market stocks trading at big discounts based on…
When it comes to the nascent – but rapidly growing – gene editing space, the author of today’s article notes that “sector players are rapidly making progress in combating rare or difficult to treat diseases that traditional chemical based drugs simply cannot accomplish.” With the market for gene editing therapies expected to grow by over 18% annually, he highlights two…
Morgan Stanley’s chief US equity strategist believes that stocks hit their true bottom on March 23rd – and that the current rally could well lead to a true recovery. To prepare for the next bull run, he’s advising clients to buy into small-cap stocks, so today’s article highlights “three micro-cap penny stock companies with super-low entry costs (a dollar per…
“While the overall market flirts with a bear, OTC stocks have been on fire,” observes the author of today’s article. And while he acknowledges that OTC stocks strike fear in many people, he reveals that many of his trades recently have been OTC stocks – and he outlines how to play it safe while playing with OTC stocks. For “the…
There was a time when people didn’t worry about retirement, because there was no such thing. Rather, with significantly shorter life expectancies, most people worked until they died. As the author of today’s article notes, “The average American now retires at age 62 while 100 years ago, the average American died at age 51” – and this development has some…
Despite being very conservative and diversified, the author of today’s article’s retirement portfolio did slightly worse than the Dow last year, with every single one of his holdings (other than cash) posting a loss – his worst return since 2008. Having lost 10% of his net worth, and believing that 2019 could be even worse for the markets than 2018,…
The widely referenced 4% rule suggests that retirees can safely withdraw that amount from their retirement accounts each year. However, the author of today’s article notes that the “wisdom” of the 4% rule collapses when it slams into the reality of a market slump. Instead, he advocates for another strategy for funding your golden years: “investments paying outsized cash dividends…